← Open Payments lookup

JENNA KOPP: Open Payments

NPI 1851023345 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$89,954 in 217 payments from 17 companies in 2025. Trend: 2023 $10,647 · 2024 $39,053 · 2025 $89,954

Speaker / faculty: $64,722Travel & lodging: $17,851Food & beverage: $3,931Consulting: $3,450
CompanyPaymentsAmount
Janssen Biotech, Inc.64$45,718
ABBVIE INC.61$23,032
Lilly USA, LLC37$20,259
Gilead Sciences, Inc.10$181
Madrigal Pharmaceuticals8$139
GENZYME CORPORATION6$138
Takeda Pharmaceuticals U.S.A., Inc.9$136
Amgen Inc.6$115
Intercept Pharmaceuticals, Inc.3$53
Phathom Pharmaceuticals, Inc.5$36

Products named: TREMFYA, OMVOH, SKYRIZI, RINVOQ, STELARA, DUPIXENT, REZDIFFRA, UPLIZNA.

Industry payments across NE — which companies pay providers there.